[1]CurrentPatentAssignee:JOHNSON&JOHNSONINC-US2012/202856,2012,A1
[1]CurrentPatentAssignee:JOHNSON&JOHNSONINC-US2012/202856,2012,A1Locationinpatent:Page/Pagecolumn40
[1]CurrentPatentAssignee:THERAVANCEBIOPHARMA,INC.-US2014/45906,2014,A1Locationinpatent:Page/Pagecolumn0394;0395
14633-21-7
14633-22-8
121604-45-3
133674-40-5
71502-42-6
870704-25-9
1244855-70-6 | 7-Benzyl-5-bromo-4-chloro-7h-pyrrolo[2,3-d]pyrimidine | AA00HHLD | MFCD20922796
16258-80-3 | 1H-Pyrazole-3,4-diamine; sulfuric acid | AA00HYOZ | MFCD28501207
56255-31-3 | (S)-2-Palmitamidopropanoic acid | AA00I9YX | MFCD26793456
95154-01-1 | 2-(1,3-Benzothiazol-2-ylthio)succinic acid | AA00IIOW | MFCD00134692
1372124-90-7 | 1,3-Diisopropylimidazolium Hydrogencarbonate (contains varying amounts of 1,3-Diisopropylimidazolium-2-carboxylate) | AA00IMEF | MFCD31618137
1421607-32-0 | 2-(3,5-dimethylphenoxy)-1-[(3R)-3-methylpiperazin-1-yl]ethan-1-one | AA01A0DY | MFCD22392058
1807941-59-8 | tert-butyl 4-(hydroxymethyl)-2-methylpiperidine-1-carboxylate, cis | AA01BBL8 | MFCD28506067
160430-64-8 | Ethanimidamide, N-[(6-chloro-3-pyridinyl)methyl]-N'-cyano-N-methyl-,(1E)- | AA01DN5V | MFCD06201842
1177798-88-7 | N,N’-[9[[4-(Dimethylamino)phenyl]amino]-3,6-acridinediyl]bis-1-pyrrolidinepropanamideTrihydrochloride | AA01DZQU | MFCD23380200
1823939-03-2 | 4-(Bicyclo[1.1.1]pentan-1-yl)phenol | AA01FG2T | MFCD27996112
